8,927 Shares of UnitedHealth Group Incorporated $UNH Bought by Venture Visionary Partners LLC

Key Points

• Venture Visionary Partners initiated a UnitedHealth Group position by purchasing 8,927 shares worth approximately $3.28 million. Institutional investors and hedge funds collectively own 87.86% of the company.
• Analysts maintain a favorable outlook, with 20 Buy ratings and eight Holds, producing a consensus rating of “Moderate Buy” and an average price target of $465.75.
• UnitedHealth reported quarterly earnings of $6.38 per share, exceeding estimates of $4.94, and revenue of $112.03 billion. The company also pays a $2.32 quarterly dividend, equivalent to a 2.5% annual yield.

Venture Visionary Partners LLC purchased a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 8,927 shares of the healthcare conglomerate's stock, valued at approximately $3,277,000.

A number of other hedge funds also recently made changes to their positions in UNH. BlackRock Inc. increased its holdings in shares of UnitedHealth Group by 4.6% during the 2nd quarter. BlackRock Inc. now owns 76,863,061 shares of the healthcare conglomerate's stock worth $31,946,594,000 after acquiring an additional 3,395,530 shares during the last quarter. State Street Corp lifted its holdings in UnitedHealth Group by 0.7% during the 2nd quarter. State Street Corp now owns 45,633,267 shares of the healthcare conglomerate's stock valued at $18,966,555,000 after purchasing an additional 301,081 shares during the last quarter. Bank of New York Mellon Corp increased its holdings in shares of UnitedHealth Group by 6.1% in the second quarter. Bank of New York Mellon Corp now owns 10,704,994 shares of the healthcare conglomerate's stock valued at $4,449,317,000 after purchasing an additional 616,723 shares during the last quarter. Wellington Management Group LLP lifted its stake in shares of UnitedHealth Group by 5.8% during the 2nd quarter. Wellington Management Group LLP now owns 10,675,175 shares of the healthcare conglomerate's stock worth $4,436,923,000 after buying an additional 583,536 shares during the last quarter. Finally, Corient Private Wealth LP boosted its holdings in shares of UnitedHealth Group by 1,443.7% during the 2nd quarter. Corient Private Wealth LP now owns 8,447,224 shares of the healthcare conglomerate's stock worth $3,510,920,000 after buying an additional 7,900,011 shares during the period. 87.86% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on UNH shares. Argus raised their price objective on shares of UnitedHealth Group from $400.00 to $470.00 and gave the stock a "buy" rating in a research report on Monday, July 20th. Mizuho increased their target price on UnitedHealth Group from $470.00 to $493.00 and gave the stock an "outperform" rating in a research note on Monday, July 20th. Barclays boosted their price target on UnitedHealth Group from $429.00 to $441.00 and gave the company an "overweight" rating in a research note on Monday, July 20th. TD Cowen lifted their target price on UnitedHealth Group from $337.00 to $430.00 and gave the stock a "hold" rating in a report on Tuesday, July 14th. Finally, Raymond James Financial upped their price target on shares of UnitedHealth Group from $370.00 to $460.00 and gave the company an "outperform" rating in a research note on Tuesday, July 14th. Twenty investment analysts have rated the stock with a Buy rating and eight have given a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $465.75.

UnitedHealth Group Trading Down 0.3%

UNH opened at $375.23 on Thursday. The company has a quick ratio of 0.78, a current ratio of 0.78 and a debt-to-equity ratio of 0.66. UnitedHealth Group Incorporated has a twelve month low of $255.96 and a twelve month high of $461.62. The stock has a market capitalization of $336.80 billion, a price-to-earnings ratio of 24.15, a P/E/G ratio of 1.41 and a beta of 0.60. The company has a 50-day simple moving average of $390.52 and a 200 day simple moving average of $379.64.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share for the quarter, topping analysts' consensus estimates of $4.94 by $1.44. The company had revenue of $112.03 billion during the quarter, compared to the consensus estimate of $110.81 billion. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. The firm's quarterly revenue was up .4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $4.08 EPS. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. Analysts predict that UnitedHealth Group Incorporated will post 19.85 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 22nd. Stockholders of record on Monday, September 14th were paid a $2.32 dividend. The ex-dividend date was Monday, September 14th. This represents a $9.28 annualized dividend and a dividend yield of 2.5%. UnitedHealth Group's dividend payout ratio (DPR) is presently 59.72%.

More UnitedHealth Group News

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Analysts continue to identify UnitedHealth as a potential value opportunity after its recovery from earlier lows. Supporters point to improving margins, Medicare Advantage stabilization and the strength of the Optum businesses. Here's Why UnitedHealth Group Is a Strong Value Stock
• Positive Sentiment: UnitedHealth was included among stocks discussed on CNBC’s “Final Trades,” providing some additional visibility and suggesting that at least some market participants view the shares favorably. EQT, UnitedHealth, Clearway Energy and More on CNBC’s Final Trades
• Neutral Sentiment: UnitedHealth’s after-hours indication was reported above the prior close, but the brief market update provided no fundamental catalyst or new company announcement to explain the move. UnitedHealth Group Stock After-Hours Update
• Neutral Sentiment: UnitedHealth is projected to report third-quarter results soon. Investors will focus on whether medical-cost trends remain manageable, Medicare Advantage margins improve and membership declines are contained. UnitedHealth Q3: Two Questions Investors Cannot Ignore
• Negative Sentiment: A bearish analysis argues that much of the recovery in margins, Medicare Advantage and Optum Health is already reflected in the valuation, leaving limited upside and little margin for execution mistakes amid elevated medical-cost inflation. UnitedHealth: The Upside Is Gone
• Negative Sentiment: Coverage disruptions affecting some Medicare members have raised concerns about plan availability and could intensify scrutiny of UnitedHealth’s Medicare business, even though some investors view the disruption as a turnaround opportunity. Medicare Plans Are Shutting Down

Insider Buying and Selling at UnitedHealth Group

In related news, CEO Patrick Conway sold 1,169 shares of the firm's stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $390.00, for a total value of $455,910.00. Following the sale, the chief executive officer directly owned 15,328 shares of the company's stock, valued at $5,977,920. This trade represents a 7.09% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. 0.19% of the stock is currently owned by corporate insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated NYSE: UNH is a diversified health care and well-being company serving individuals, employers, health care providers and government programs. Its operations are organized primarily through UnitedHealthcare and Optum.

UnitedHealthcare provides health benefit plans and services, including employer-sponsored coverage, individual and family plans, Medicare and Medicaid offerings, and other government-supported programs. Its services include health insurance administration, pharmacy benefits and care management.

Optum provides health care services, technology and data solutions, pharmacy services, and analytics to health plans, employers, government agencies, health care providers and consumers.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.